A citation-based method for searching scientific literature

Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O Lindsay, Laurent Peyrin-Biroulet, Garret J Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J Mantzaris, Fernando Rizzello, Stephan Vavricka, Paolo Gionchetti. J Crohns Colitis 2017
Times Cited: 1015







List of co-cited articles
548 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B Gecse, Ailsa L Hart, Pieter Hindryckx,[...]. J Crohns Colitis 2017
790
30

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.
Christian Maaser, Andreas Sturm, Stephan R Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C Baumgart, Dominik Bettenworth, Paula Borralho Nunes,[...]. J Crohns Colitis 2019
439
16


Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
15

A simple index of Crohn's-disease activity.
R F Harvey, J M Bradshaw. Lancet 1980
11

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
821
11

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
11

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian,[...]. J Crohns Colitis 2017
579
11

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager,[...]. J Crohns Colitis 2020
297
10


Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
9

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
545
9

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
9

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D'Amico, Jasbir Dhaliwal, Anne M Griffiths, Dominik Bettenworth, William J Sandborn, Bruce E Sands, Walter Reinisch,[...]. Gastroenterology 2021
236
8

Crohn's disease.
Daniel C Baumgart, William J Sandborn. Lancet 2012
7

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.
Paolo Gionchetti, Axel Dignass, Silvio Danese, Fernando José Magro Dias, Gerhard Rogler, Péter Laszlo Lakatos, Michel Adamina, Sandro Ardizzone, Christianne J Buskens, Shaji Sebastian,[...]. J Crohns Colitis 2017
349
7

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L Peyrin-Biroulet, W Sandborn, B E Sands, W Reinisch, W Bemelman, R V Bryant, G D'Haens, I Dotan, M Dubinsky, B Feagan,[...]. Am J Gastroenterol 2015
7

Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
Natalie A Molodecky, Ing Shian Soon, Doreen M Rabi, William A Ghali, Mollie Ferris, Greg Chernoff, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Herman W Barkema,[...]. Gastroenterology 2012
7

ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. Am J Gastroenterol 2018
483
7

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
7

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Stephen B Hanauer, William J Sandborn, Paul Rutgeerts, Richard N Fedorak, Milan Lukas, Donald MacIntosh, Remo Panaccione, Douglas Wolf, Paul Pollack. Gastroenterology 2006
7

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
780
7

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
Laurent Peyrin-Biroulet, Walter Reinisch, Jean-Frederic Colombel, Gerassimos J Mantzaris, Asher Kornbluth, Robert Diamond, Paul Rutgeerts, Linda K Tang, Freddy J Cornillie, William J Sandborn. Gut 2014
319
6

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
Marco Daperno, Geert D'Haens, Gert Van Assche, Filip Baert, Philippe Bulois, Vincent Maunoury, Raffaello Sostegni, Rodolfo Rocca, Angelo Pera, Annemie Gevers,[...]. Gastrointest Endosc 2004
897
6

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Filip Baert, Liesbeth Moortgat, Gert Van Assche, Philip Caenepeel, Philippe Vergauwe, Martine De Vos, Pieter Stokkers, Daniel Hommes, Paul Rutgeerts, Severine Vermeire,[...]. Gastroenterology 2010
616
6

Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography.
Fabiana Castiglione, Pier Paolo Mainenti, Giovanni Domenico De Palma, Anna Testa, Luigi Bucci, Giuseppe Pesce, Luigi Camera, Maria Diaferia, Matilde Rea, Nicola Caporaso,[...]. Inflamm Bowel Dis 2013
92
6

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian D R Arnott, Charles N Bernstein, Steven R Brant, Renzo Caprilli, Jean-Frédéric Colombel, Christoph Gasche, Karel Geboes,[...]. Can J Gastroenterol 2005
6

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
235
6

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, Robert Enns, Stephen B Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D Kent,[...]. Gastroenterology 2007
6

Biologic agents for IBD: practical insights.
Silvio Danese, Lucine Vuitton, Laurent Peyrin-Biroulet. Nat Rev Gastroenterol Hepatol 2015
187
5

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
Mahmoud H Mosli, Guangyong Zou, Sushil K Garg, Sean G Feagan, John K MacDonald, Nilesh Chande, William J Sandborn, Brian G Feagan. Am J Gastroenterol 2015
304
5

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.
Andreas Sturm, Christian Maaser, Emma Calabrese, Vito Annese, Gionata Fiorino, Torsten Kucharzik, Stephan R Vavricka, Bram Verstockt, Patrick van Rheenen, Damian Tolan,[...]. J Crohns Colitis 2019
128
5

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
Anthony Buisson, Florent Gonzalez, Florian Poullenot, Stéphane Nancey, Elisa Sollellis, Mathurin Fumery, Benjamin Pariente, Mathurin Flamant, Caroline Trang-Poisson, Guillaume Bonnaud,[...]. Inflamm Bowel Dis 2017
81
6

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.
Marco Pennazio, Cristiano Spada, Rami Eliakim, Martin Keuchel, Andrea May, Chris J Mulder, Emanuele Rondonotti, Samuel N Adler, Joerg Albert, Peter Baltes,[...]. Endoscopy 2015
419
5

Long-term evolution of disease behavior of Crohn's disease.
Jacques Cosnes, Stéphane Cattan, Antoine Blain, Laurent Beaugerie, Franck Carbonnel, Rolland Parc, Jean-Pierre Gendre. Inflamm Bowel Dis 2002
913
5

Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Bruce E Sands, Brian G Feagan, Paul Rutgeerts, Jean-Frédéric Colombel, William J Sandborn, Richmond Sy, Geert D'Haens, Shomron Ben-Horin, Jing Xu, Maria Rosario,[...]. Gastroenterology 2014
426
5

European evidence based consensus for endoscopy in inflammatory bowel disease.
Vito Annese, Marco Daperno, Matthew D Rutter, Aurelien Amiot, Peter Bossuyt, James East, Marc Ferrante, Martin Götz, Konstantinos H Katsanos, Ralf Kießlich,[...]. J Crohns Colitis 2013
490
5

Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.
J Panes, Y Bouhnik, W Reinisch, J Stoker, S A Taylor, D C Baumgart, S Danese, S Halligan, B Marincek, C Matos,[...]. J Crohns Colitis 2013
381
5

Infliximab for the treatment of fistulas in patients with Crohn's disease.
D H Present, P Rutgeerts, S Targan, S B Hanauer, L Mayer, R A van Hogezand, D K Podolsky, B E Sands, T Braakman, K L DeWoody,[...]. N Engl J Med 1999
5

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.
J Panés, R Bouzas, M Chaparro, V García-Sánchez, J P Gisbert, B Martínez de Guereñu, J L Mendoza, J M Paredes, S Quiroga, T Ripollés,[...]. Aliment Pharmacol Ther 2011
377
5

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
342
5

The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, William Sandborn, Silvio Danese, Geert D'Haens, Remo Panaccione, Edward V Loftus, Serap Sankoh, Irving Fox,[...]. Gut 2017
426
5

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
5

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
William J Sandborn, Christopher Gasink, Long-Long Gao, Marion A Blank, Jewel Johanns, Cynthia Guzzo, Bruce E Sands, Stephen B Hanauer, Stephan Targan, Paul Rutgeerts,[...]. N Engl J Med 2012
731
5

Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.
Torsten Kucharzik, Bianca M Wittig, Ulf Helwig, Norbert Börner, Alexander Rössler, Stefan Rath, Christian Maaser. Clin Gastroenterol Hepatol 2017
92
5

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne,[...]. Lancet 2017
409
5

Ultrasound as a diagnostic tool in detecting active Crohn's disease: a meta-analysis of prospective studies.
Jianning Dong, Honggang Wang, Jie Zhao, Weiming Zhu, Liang Zhang, Jianfeng Gong, Yi Li, Lili Gu, Jieshou Li. Eur Radiol 2014
52
7

Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
A J Yarur, V Kanagala, D J Stein, F Czul, M A Quintero, D Agrawal, A Patel, K Best, C Fox, K Idstein,[...]. Aliment Pharmacol Ther 2017
159
4

Predictors of Crohn's disease.
Laurent Beaugerie, Philippe Seksik, Isabelle Nion-Larmurier, Jean-Pierre Gendre, Jacques Cosnes. Gastroenterology 2006
616
4

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.
David A Schwartz, Edward V Loftus, William J Tremaine, Remo Panaccione, W Scott Harmsen, Alan R Zinsmeister, William J Sandborn. Gastroenterology 2002
601
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.